Several studies demonstrated that elevation of preoperative CEA and CA19-9 could serve as independent prognostic factors for patients underwent radical surgery.[7,12,13] Nam et al[14] reported that early postoperative tumor marker levels might be used for the prediction of survival of GC patients. The gene discussed is CEACAM5; the disease is gastric cancer.